2017 Genome Editing Training Course.

Card CremonaGenome Editing in Pigs for Xenotransplantation.

The TRANSLINK project funded by the European Commission 7th Framework Program will be hosting the “2017 Genome Editing Training Course” in Avantea facilities, Cremona, Italy on Monday May 15th through Wednesday May 17th. The goal of this meeting is to expose international students to the fast evolving field of large animals’ genetic engineering, to foster interactions and promote the latest technology for genome editing in mammals using CRISPR/Cas9 with particular reference to genome editing for xenotransplantation. The course will feature a series of introductory lectures followed by hands-on training.

The course will cover these major themes:

  • Requirements for xenotransplantation
  • Genetic engineering of large animals
  • Conception and design of genome editing nucleases
  • Editing in somatic cell cultures and selection of mutant cells
  • Somatic cell nuclear transfer to generate embryos for transfer to surrogates mothers
  • Birth of offspring and genetic analysis

Visit the training course web page: http://www.translinkproject.com/training-course-2017/

TransLink and Xenoislet: Europe is taking the lead in Xenotransplatation


On the 9th of November 2016, the European Collaborative projects TransLink and Xenoislet joined together in a public dissemination event: the Conference on “Research on animal-derived products for use in the clinic – Results from EU collaborative projects”.

Students and international professionals attended the iconic Wilkins Main Building at University College London and got key insights into xenotransplantation for both heart valve deterioration and diabetes treatment from the top experts in the fields.

The conference aimed to promote the international exchange of the latest concepts, innovative techniques and results in the field of cardiovascular valve transplantation, glycoimmunology, pancreatic islets and innovative diabetes treatment, offering participants the opportunity to
outstanding scientific leaders and researchers.

Dr Emanuele Cozzi (Azienda Ospedaliera di Padova, Italy) (above, right) and Prof Pierre Gianello (Catholic University of Louvain, Belgium) (above, left), co-ordinators of TransLink and Xenoislet, respectively, led the Conference which gathered experts from hospitals, academia and companies focused on the research, understanding and creation of real solutions inheart valve pathology and diabetes.

Furthermore, the event was attended by Dr Charles Kessler, Research Directorate-General of the European Commission, who provided insight into the thinking of the European Commission and global challenges, as well as the importance of collaborative research for addressing such challenges.

Meet the experts behind our EU collaborative projects, discover their objectives and results:

  • TransLink “Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves” and
  • Xenoislet “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2”

Angela Barone at XXII Nordic Molecular Glycobiology Meeting

Angela Barone from University of Gothemborg (UGOT) will give a TranLink presentation on “Glycosphingolipids of porcine, bovine and  equine pericards as potential immune targets in biological heart valve grafts” at the XXIIth  Nordic Molecular Glycobiology Meeting in Copenhagen.


The meeting will be held during the 9th and 10th of December at University of Copenhagen. This offers an ideal opportunity for junior researchers to present their work in an informal atmosphere, and for researchers at all levels to network and discuss different aspects of glycobiology. The meeting accomodates about 80 participants from Sweden, Norway, Finland, Germany and Denmark, with 26 talks distributed over two days.

Here the agenda of the meeting

InKemia IUCT group receive the Gold Medal for Merit in Work


The European Association of Economy and Competitiveness give to Inkemia IUCT group the Gold Medal for Merit in Work in recognition of its professional trajectory, excellent labour during and experience in the Pharmaceutical sector and customer satisfaction for the service provided.

This ceremony was taken place in November at Hotel Westin Palace in Madrid. The distinctions were given by The president of honour of the European Association of Economy and Competitiveness, Hon. Myriam de la Sierra and Urquijo and the price was received by the director of Inkemia Madrid Dr Adrián García on behalf of the CEO Dr Josep Castells.

The Gold Medal for Merit in Work awarded by the AEEC represents excellence and entrepreneurship, contributing to a sustainable and inspiring entrepreneurial European environment, which fosters good economic and social development. By obtaining this award institutions may encourage communication in different professional sectors of convenience as well as a loyalty of your prospects.


Dr. Jean-Paul Solillou awarded with Medawar Prize 2016

This year Dr. Solillou from INSERM, has been awarded with the prestigious Medawar Prize of The Transplantation Society.


The Medawar Prize, named after Society co-founder Sir Peter Medawar, is recognized as the world’s highest dedicated award for the most outstanding contributions in the field of transplantation. The Medawar Prize has been awarded at each of our Society’s biennial Congresses since 1990.

The award recognizes the outstanding investigators whose contributions have had such a profound influence on the field of organ transplantation. The Medawar Prize is universally considered to be commensurate with the most outstanding world prizes for scientific achievement.


TransLink – Xenoislet Joint Conference

Next Wednesday, November 9th , University College London will host the important Joint Dissemination Event “Research on animal-derived products for use in the clinic – Results from EU collaborative projects”.

This event brings together two international projects, TransLink (www.translinkproject.com) and XenoIslet (http://xenoislet.eu), funded by the European Union’s Seventh Framework Programme for Research and Technological Development.

The conference aims to promote the international exchange of the latest concepts, innovative techniques and results in the field of  cardiovascular valve transplantation, glycoimmunology,  pancreatic islets  and innovative diabetes treatment,offering participants the opportunity to
outstanding scientific leaders and researchers.

[for any further information, interested parties should refer to Prof Pierre Gianello, M.D., PhD. (pierre.gianello@uclouvain.be) or Dr Emanuele Cozzi, M.D., Ph.D. (Emanuele.cozzi@unipd.it) who are the coordinators of the two FP7 EU-funded projects]

Save the Date! Joint TransLink – Xenoislet Conference 2016

Students, researchers, doctors, and scientists in general, you are all invited to the Joint TransLink – Xenoislet Conference “Research on animal-derived products for use in the clinic”. Results from these two EU collaborative projects will be presented in London on the 9th of November 2016.

During this day, relevant expert speakers will share with you new insights in cardiovascular xenotransplantation, glycoimmunology and cutting edge technologies in Drug Design as well as in pancreatic islets, and pig islet xenotransplantation for diabetes treatment research.

Meet the experts behind our EU collaborative projects

  • TransLink “Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves” and
  • Xenoislet “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2”

And hear from their project leaders

  • Dr Emanuele Cozzi, Azienda Ospedaliera di Padova – Italy
  • Prof Pierre Gianello, Catholic University of Louvain – Belgium

Come to this Open Conference. To register, please send an email to communication@translinkproject.com indicating:

  • First Name
  • Last Name
  • Email address
  • Company/University/Group

See you soon!

The agenda and all details can be found at: www.translinkproject.com/dissemination-conference-2016/


Heart Valve Society Annual Meeting

The Annual Meeting of the Heart Valve Society will start this week. During the 17th to 19th of March at New Youk city the top international sciencist will share their knowledge and interesting progress in the Heart Valves field.


Among the experts some participants of TransLink project are sharing the relevant and high-impact results arising from the project.

Do not miss their oral presentations:

  • Dr. Rafael Mañez (ICS-HUB): The role of oxidative and nitrosative stress in the serum of patients with SVD
  • Dr. Vered Padler-Karavani (TAU): Immunogenic non-human carbohydrate antigen expression in bioprostheses. Potential link to structural deterioration
  • Dr. Manuel Galiñanes (ICS_UHVE):  Redox status in explanted native and bioprosthetic aortic valves. Retrospective and prospective study on the role of oxidative and nitrosative stress in structural valve disease.

For more information: http://heartvalvesociety.org/




Dr. Vered Padler-Karavani at NanoIsrael 2016


This week The 5th International Nanotechnology Conference & Exibition took place at Tel Aviv with the representation of our TransLink partner Tel Aviv University.

The NanoIsrael has established itself as the central meeting point for local and multinational companies, investors, university and corporate research scientists and government representatives from around the world. Bringing together elite speakers and top individuals from academia, business and government. During the two days of conference keynote speakers share their knowledge in the field of nanotechnology. Among the experts our partner Dr. Vered Padler-Karavani (TAU) presented: Targeting the sweet side of cancer with glyco-nanoparticle.


See more details about the event at: http://www.kenesexhibitions.com/nanoisrael2016/welcome-letter/#sthash.0nL9Amod.dpuf

TAU Trust – University for a Day 2016

The TransLink project is pleased to announce our colleague Dr. Vered Padler-Karavani (Tel Aviv University) will participate as a speaker at University for a Day 2016.

The event will be held the 7th of February in London and speakers will discuss topics including Cyber threats, Cancer, Stem Cells and Relations in the Middle East. Specifically Dr. Padler-Karavani will present “Aiming at the Sweet Spot of Disease: Targeting sugars in heart disease and Cancer“.


Don’t miss it!